78 results
8-K
BMY
Bristol-Myers Squibb Co.
18 Jun 24
Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors
4:23pm
determined that Mr. McMullen is independent under the New York Stock Exchange Listing Standards and the independence standards adopted by the Board. He
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
8 Jan 24
Regulation FD Disclosure
10:29am
USE
Reblozyl: Significant growth opportunities in MDS-associated anemia and beyond Ongoing registrational studies 1L TD myelofibrosis(INDEPENDENCE
8-K
EX-1.1
6wisg7
13 Nov 23
Other Events
4:19pm
424B5
ot2lbs raq7c
1 Nov 23
Prospectus supplement for primary offering
4:16pm
FWP
amwiy4
30 Oct 23
Free writing prospectus
5:26pm
8-K
EX-99.2
imuqe3gd6b l8
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
zibzztllv ekvjxyjm5
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.2
4haqb2xgvg
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
w3gqyq8nqd6xcn
4 May 23
Departure of Directors or Certain Officers
4:48pm
8-K
EX-99.2
gn1nbpb yb0dnt2
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
xc4oq3
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.3
4bp2w1kfrrj zybks8rj
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.3
uuu c3lwq5be
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
2iytjmlwr5e2inss4mx
15 Jun 22
Departure of Directors or Certain Officers
4:29pm
8-K
EX-99.3
pykcnll3ng sn
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
f7zn evkuxt
20 Apr 22
Additional proxy soliciting materials
4:30pm